Saudi Arabia's seven-year diplomatic freeze and proxy conflict with Iran appears to have come to an end after China brokered…
McAlinden Research PartnersMarch 16, 2023
Pfizer's acquisition of Seagen, which is the largest biopharma deal since 2019, comes as products received in previous deals begin…
McAlinden Research PartnersMarch 14, 2023
Later today, President Biden will propose a federal budget allocation for the fiscal year 2024. Among other line items, the Space…
McAlinden Research PartnersMarch 9, 2023
TikTok, the most widely used and downloaded app around the world, may soon be facing a ban in the United…
McAlinden Research PartnersMarch 8, 2023
With just 10 days to go before the Black Sea Grain Initiative is set to expire, posturing by Russia suggests…
McAlinden Research PartnersMarch 7, 2023
Oil Markets Struggle for Direction Amid Chinese Demand Disappointment and American Drilling Slowdown
Mixed signals in energy markets have struggled to give any clear direction to oil prices so far this year. While…
McAlinden Research PartnersMarch 6, 2023
Several key data points appear to indicate China's economic recovery, following an extended bout of COVID-induced lockdowns, has taken hold.…
McAlinden Research PartnersMarch 2, 2023
With generative AI becoming tech's latest breakout trend, the biggest brands in social media and search engines are racing to…
McAlinden Research PartnersMarch 1, 2023
A potential acquisition of Seagen by Pfizer, likely in the neighborhood of $40.0 billion, would be the biggest biopharma deal…
McAlinden Research PartnersFebruary 27, 2023
